Page 87 - Read Online
P. 87

Page 16 of 19        Deivasigamani et al. Mini-invasive Surg 2023;7:9  https://dx.doi.org/10.20517/2574-1225.2022.99

               Conflict of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2023.


               REFERENCES
               1.       Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33.  DOI  PubMed
               2.       Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH. Trends in renal-cell carcinoma incidence and mortality in the
                    United States in the last 2 decades: a SEER-based study. Clin Genitourin Cancer 2019;17:46-57.e5.  DOI  PubMed  PMC
               3.       Conti A, Santoni M, Sotte V, et al. Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and
                    risk of metastasis. Urol Oncol 2015;33:303-9.  DOI  PubMed
               4.       Cooper IS. Cryobiology as viewed by the surgeon. Cryobiology 1964;1:44-51.  DOI  PubMed
               5.       Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998;37:171-86.  DOI  PubMed
               6.       Kaouk JH, Aron M, Rewcastle JC, Gill IS. Cryotherapy: clinical end points and their experimental foundations. Urology 2006;68:38-
                    44.  DOI  PubMed
               7.       Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors.
                    Cryobiology 2014;68:1-11.  DOI  PubMed  PMC
               8.       Kwak K, Yu B, Lewandowski RJ, Kim DH. Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.
                    Theranostics 2022;12:2175-204.  DOI  PubMed  PMC
               9.       Breda A, Lam JS, Riggs S, et al. In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines
                    for the practicing urologist. J Urol 2008;179:333-7.  DOI  PubMed
               10.       Mues AC, Landman J. Image-guided percutaneous ablation of renal tumors: outcomes, technique, and application in urologic
                    practice. Curr Urol Rep 2010;11:8-14.  DOI  PubMed
               11.       Rioja J, Tzortzis V, Mamoulakis C, Laguna MP. [Cryotherapy for renal tumors: current status and contemporary developments].
                    Actas Urol Esp 2010;34:309-17.  PubMed
               12.       Buy X, Lang H, Garnon J, Sauleau E, Roy C, Gangi A. Percutaneous renal cryoablation: prospective experience treating 120
                    consecutive tumors. AJR Am J Roentgenol 2013;201:1353-61.  DOI  PubMed
               13.       Tsoumakidou G, Buy X, Garnon J, Enescu J, Gangi A. Percutaneous thermal ablation: how to protect the surrounding organs. Tech
                    Vasc Interv Radiol 2011;14:170-6.  DOI  PubMed
               14.       Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or
                    cryoablation - what should you use and why? Radiographics 2014;34:1344-62.  DOI  PubMed  PMC
               15.       Seager M, Kumar S, Lim E, Munneke G, Bandula S, Walkden M. Renal cryoablation - a practical guide for interventional
                    radiologists. Br J Radiol 2021;94:20200854.  DOI  PubMed  PMC
               16.       Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management,
                    and follow-up: AUA guideline: part I. J Urol 2021;206:199-208.  DOI
               17.       Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl
                    Compr Canc Netw 2022;20:71-90.  DOI
               18.       Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update.
                    Eur Urol 2022;82:399-410.  DOI
               19.       Morris CS, Baerlocher MO, Dariushnia SR, et al. Society of interventional radiology position statement on the role of percutaneous
                    ablation in renal cell carcinoma: endorsed by the canadian association for interventional radiology and the society of interventional
                    oncology. J Vasc Interv Radiol 2020;31:189-194.e3.  DOI  PubMed
               20.       Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS. Minimally invasive ablative approaches in the treatment of
                    renal cell carcinoma. Curr Urol Rep 2002;3:13-20.  DOI  PubMed
               21.       Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of
                    retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol 2008;19:1034-40.  DOI  PubMed
               22.       Rodríguez-Faba O, Palou J, Rosales A, et al. Prospective study of ultrasound-guided percutaneous renal cryotherapy: case selection
                    as an optimization factor for a technique. Actas Urol Esp 2015;39:8-12.  DOI  PubMed
               23.       Marion JT, Schmitz JJ, Schmit GD, et al. Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumor
   82   83   84   85   86   87   88   89   90   91   92